BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Month: February 2022

3 posts
Celyad-Oncology-Pauses-CYAD-101-002-Keynote-B79-Phase-1-Trial-After-2-Deaths-Reported

Biotech NewsCelyad Oncology Pauses CYAD-101-002 (Keynote-B79) Phase 1 Trial After 2 Deaths Reported

  • BioTech Health X
  • February 28, 2022
Clinical-stage biotechnology company Celyad Oncology (NASDAQ: CYAD) recently announced that the company has voluntarily paused the CYAD-101-002 (KEYNOTE-B79)…
0 Shares
0
0
0
0
0
0
0
Cellarity-Expands-Leadership-Team-to-Continue-Evolution-of-Breakthrough-Platform-to-Encode-Biology-and-Purposefully-Create-New-DrugsCellarity-Expands-Leadership-Team

Biotech NewsCellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs

  • BioTech Health X
  • February 10, 2022
With the appointments of these experts, the firm has added to its industry knowledge, including Chief Scientific Officer…
0 Shares
0
0
0
0
0
0
0
BioTech Health X CEO Series Virios Therapeutics Greg Duncan

BioTech CEO InterviewsBioTech Health X CEO Series: Virios Therapeutics Greg Duncan

  • BioTech Health X
  • February 1, 2022
BioTech Health X works to deliver the latest coverage and updates in the biotechnology sector. This includes providing…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • Syndax (SNDX) Up 15% in 6 Months — Analysts See $56 High
  • Trulieve Cannabis (TCNNF) Posts $302M Q2 Revenue but Still Reports $14M Net Loss
  • BioCryst Pharmaceuticals (BCRX) Posted Q2 49.5% Revenue Surge
  • Novo Nordisk (NVO) Crashes 21.83% in One Day
  • Connect Biopharma (CNTB) Trades at $1.63 With $7.00 Analyst Target
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • September 17, 2025
    Syndax (SNDX) Up 15% in 6 Months — Analysts See $56 High
    • September 17, 2025
    Trulieve Cannabis (TCNNF) Posts $302M Q2 Revenue but Still Reports $14M Net Loss
    • September 17, 2025
    BioCryst Pharmaceuticals (BCRX) Posted Q2 49.5% Revenue Surge
    • September 17, 2025
    Novo Nordisk (NVO) Crashes 21.83% in One Day
    • September 17, 2025
    Connect Biopharma (CNTB) Trades at $1.63 With $7.00 Analyst Target
Recent Posts
  • Ocean Biomedical (OCEA) Warned Over Missed $612,581 Milestone
    • September 17, 2025
  • Greenwich LifeSciences (GLSI)’ GLSI-100 Cuts Breast Cancer Recurrence by 80% in Trials
    • September 17, 2025
  • SELLAS Life (SLS) Secures $23.6M to Fuel Late-Stage Cancer Trials
    • September 17, 2025
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (1)
  • Biotech News (395)
  • Uncategorized (1)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top